We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBO Puts $872M Price Tag on 21st Century Cures Act’s FDA Initiatives
CBO Puts $872M Price Tag on 21st Century Cures Act’s FDA Initiatives
The Congressional Budget Office is estimating that provisions in the proposed drug overhaul bill, if implemented by the FDA, would cost $872 million from 2016-2020, according to a report issued Tuesday.